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HYPEROSMOLAR SOLUTIONS have been used for several purposes; to decrease brain bulk and intracranial pressure, 1 "* to increase drug delivery into the brain for the treatment of malignant brain tumors , 7 or to treat cerebral ischemia. 8 "" Intravascular infusion of hyperosmolar solutions has been shown to increase cerebral blood flow (CBF), 12~15 presumably due to a direct vasodilatory effect.
14 However, Muizelaar et al 16 have recently demonstrated that intravenous mannitol resulted in constriction of cerebral arteries. Thus, the responses of cerebral arteries to hyperosmolar solutions in vivo are controversial, and little is known about the direct effect of hyperosmolar solutions on isolated cerebral arteries in vitro.
Kent et al 17 have recently reported, using rat aortic strips, that hyperosmolar solutions may alter vasoconstriction associated with intracellular calcium mobilization rather than that associated with extracellular calcium influx. However, such a hypothesis may not be applicable to cerebral arteries, since the constrictor responses of cerebral arteries to vasoconstricting agents are mainly dependent on the influx of extracellular calcium. 18 " 22 The present study was conducted in order to examine the direct effect of hyperosmolar solutions on the constrictor responses of isolated cerebral arteries to several vasoactive agents and to elucidate the mechanisms by which hyperosmolarity might affect the vascular tone.
Materials and Methods
Adult mongrel dogs of either sex, weighing 10 to 16 kg, were anesthetized with sodium pentobarbital (30 mg/kg) and sacrificed by exsanguination from the femoral artery.
Under magnification, the basilar arteries were dissected from the brain and immediately placed in modified Kreb's bicarbonate solution [(mM): NaCl 120; KC1 4.5; MgSO 4 1.0; NaHCO 3 27.0; KH 2 PO 4 1.0; CaCl 2 2.5; and dextrose 10.0] at 37°C, which was gassed with 95% 0 2 and 5% CO 2 . The pH of the solution ranged from 7.40 to 7.50. The arteries were cut into 4 mm long ring segments and suspended between L-shaped stainless steel holders in organ baths with 10-ml working volumes. Resting tension was adjusted to 2.0 g. The preparations were allowed to equilibrate for 60 minutes before use. Contractile force was recorded isometrically using a Grass FT.03 force-displacement transducer. The transducer signal was then amplified and displayed on a Gould 260 multichannel recorder. In order to check the contractile activity of each specimen, the contractile response to 40 mM KC1 was first obtained on each ring segment. Only specimens which showed a good response to 40 mM K G were used.
In the first experiment, the effect of hyperosmolar solutions on the constrictor responses to 40 mM [K + ] o , 10~7M serotonin or 10" 6 M PGF^ was examined. The concentration of each agonist producing approximately 70% of the maximum contraction was used in the present study. The contractile activity of each agonist in the normal Kreb's solution was measured several times until the response became stable. After the response became stable, a control response was obtained. Then, the effect of mannitol or sucrose was examined. Excess In a second experiment, the PGF^-induced contractions were examined to determine whether hyperosmolar solution-induced vasodilation is dependent upon alterations of extracellular and/or intracellular calcium mobilization. The contractions o( canine cerebral artery induced by PGF^ are more dependent on intracellular calcium mobilization than are the contractions induced by other constrictor agents such as KC1 or serotonin.
19 " Therefore, it is possible using PGF^ to examine the effect of hyperosmolar solutions on both the contractions mediated through the release of intracellularly stored Ca + + and those mediated through the influx of extracellular Ca + + . The preparations were exposed to Ca ++ -free medium containing 0.5 mM ethyleneglycol-bis-(/3-aminoethylether)-N,N'-tetraacetic acid (EGTA) for 15 minutes before addition of 10" 6 M PGF^. The PGF^-induced contraction in the Ca + + -free medium was considered to result from the intracellular Ca + + mobilization. After the contraction had been stabilized, 1 mM Ca + + was then added. The contraction induced by the addition of 1 mM Ca + + was considered to result from the influx of external Ca + + . After washing the preparations with normal Kreb's solution several times, the preparations were exposed to the Ca ++ -free medium for 15 minutes and to 2% mannitol or 4% sucrose for 5 minutes before addition of 10" 6 M PGF^. In order to obtain more information about the effect of hyperosmolar solutions on calcium mobilization, the following third and fourth experiments were performed.
In a third experiment, the effect of hyperosmolar solutions on the Ca ++ -induced contractions of K + (80 mM)-depolarized arterial segments was examined. Preliminary experiments had demonstrated that 15 min exposure of the preparations to Ca ++ -free medium containing 0.5 mM EGTA inhibited completely the contractile activity of 80 mM KC1. In the present experiment, therefore, the K + (80 mM)-depolarized arteries were exposed to Ca ++ -free media containing 0.5 mM EGTA for 15 minutes before the addition of calcium. A dose-response curve for Ca + + was obtained by cumulative addition of calcium. In order to examine the effect of hyperosmolar solutions on the Ca ++ -induced contractions, the K + (80 mM)-depolarized arteries in the Ca ++ -free medium were incubated for 5 minutes with mannitol or sucrose before addition of calcium.
In a fourth experiment, the effect of mannitol on the caffeine-induced contraction in Ca ++ -free medium was examined in order to determine whether hyperosmolar solutions alter the contraction mediated by release of intracellularly stored calcium, since caffeine is known to release the intracellularly stored calcium. 24 " 25 The preparations were exposed to Ca ++ -free medium containing 0.5 mM EGTA for 15 minutes before application of 10 mM caffeine. After washing the preparations with normal Kreb's solution, the preparations were exposed to the Ca ++ -free medium for 15 minutes and to 1% mannitol for 5 minutes before application of 10 mM caffeine.
Comparisons of control and treatment responses at a specific concentration of mannitol or sucrose were done using Student's t-test. Statistical analysis of the dose-response curves of Ca ++ -induced contractions was made using analysis of variance (ANOVA). Values were considered to be significantly different at P < .05. The drugs used in this study were 5-hydroxytryptamine, prostaglandin F^, potassium chloride, calcium chloride, mannitol, sucrose, caffeine and ethyleneglycol-bis(J8-aminoetnylether)-N,N'-tetraacetic acid (EGTA, Sigma Chemical Company).
Results

Effect of Hyperosmolar Solutions on the Canine Basilar Arteries Under Resting Tension
The contractile activity of canine basilar arteries under resting tension was not altered by either 0.1% mannitol or 0.2% sucrose itself, while the arteries were slightly relaxed with both mannitol (0.5, 1 and 2%) and sucrose ( 1 , 2 and 4%) as shown in table 1.
Effect of Hyperosmolar Solution on the Constrictor Responses to 40 mM [K + ]o, 10~7 MSerotonin and 10-"M PGF 2a
As shown in figures 1 and 2, neither 0.1% mannitol nor 0.2% sucrose significantly suppressed any of the constrictor responses of canine basilar arteries to 40 mM [K + ]o, 1 0 -^ serotonin and 10" 6 M PGF^. However, the constrictor responses to those agonists were suppressed in a dose-dependent manner by the 5 minute pretreatment of preparations with either mannitol (0.5, 1, 2%) or sucrose (1,2,4%). The rate of suppression of constriction by these agonists correlated well to osmolarity changes in the Kreb's solution. Linear regression analysis was done with constrictor responses to each agonist as dependent variables and osmolarity of the Kreb's solution as the independent variable. Correlation coefficients (r) ranged from -0 . 9 0 to -0 . 9 4 and were all statistically significant (p < 0.001).
Studies of the Mechanisms of the Inhibitory Effect of Hyperosmolar Solutions on the PGF 2a -Induced Contraction
When the preparations were incubated for 15 minutes in Ca ++ -free medium containing 0.5 mM EGTA, the addition of 10~6M PGF^ elicited small contractions. Additions of 1 mM calcium to the bath promptly elicited larger contractions. These large contractions in response to the influx of extracellular calcium were markedly suppressed by the pretreatment of preparations with either 2% mannitol (86.3% ± 2.7%, Mean ± SE, n = 6) or 4% sucrose (73.5 ± 7.1%, Mean ± SE, n = 9), while the small contractions caused by the release of intracellularly bound calcium were not significantly inhibited ( fig. 3) .
Effects of Hyperosmolar solutions on the Ca ++ -Induced Contractions of the K + (80 mM)-Depolarized Arterial Segments
After arteries were depolarized by the addition of 80 mM K + , the addition of 0.5 mM Ca + + did not alter the constrictor activity. However, dose-dependent contractions of the arteries were produced by the addition of 1, 5 and 10 mM Ca + + (fig. 4 ). As shown in figure 4 the dose-response curves of Ca ++ -induced contractions were not significantly altered by pretreatment of the preparations with either 0.1% and 0.5% mannitol or 0.2% and 1% sucrose. However, the control doseresponse curve was significantly different from curves treated with mannitol at concentrations of 1 % and 2% and sucrose at concentrations of 2% and 4% (ANOVA, p < 0.001).
When one compares figures 3 (1 mM Ca ++ -induced contractions of the arteries challenged with 10" 6 M PGF^ with this contraction expressed as 100%) and 4 (1 mM Ca ++ -induced contractions of the 80 mM K + depolarized arteries which are expressed as a percentage of the standard 40 mM KC1 induced contraction), it can be seen that 2% mannitol or 4% sucrose has a significantly greater inhibitory effect on the constriction mediated through the PGF^ evoked influx of ex- tracellular calcium than on the calcium (1 mM) induced contraction mediated through influx of extracellular calcium following the K (80 mM) depolarization of the cell membranes ( fig. 5) .
Effect of Hyperosmolar Solution on the CaffeineInduced Contractions
The effect of 1 % mannitol on the caffeine-induced contractions is shown in figure 6 . When the contractions elicited by 10 mM caffeine in the Ca ++ -free medium were taken as 100%, the caffeine-induced contraction of the preparations treated with 1 % mannitol was 85.9 ± 5.0% (Mean ± S.E., n = 8). This effect is not statistically significant.
Discussion
The present results demonstrate that constrictor responses of canine basilar arteries to 40 mM[K + ]o, 10~7M serotonin and 10~" 6 M PGF^ are suppressed in a dose-dependent manner by the pretreatment of preparations with either mannitol or sucrose. The rate of suppression of constriction to these agonists correlated well to osmolarity changes in the Kreb's solution. These results indicate that hyperosmolarity produces a direct dilatory effect on the cerebral arteries.
Several hypotheses have been proposed as to the mechanisms responsible for the dilatory effect of hyperosmolar solutions, based on experimental results in peripheral vessels or skeletal muscles: (1) tion, 26 ' 29 (3) decreased actomyosin ATPase activity as a consequence of cellular dehydration, 30 (4) changes in the molecular structure of the myofilaments, 26 3h n and (5) alteration of calcium mobilization. 17 However, the precise mechanism for the dilatory effect is still unclear. Krishnamurty, et al" have reported that mannitol-induced vasodilation was not affected by beta adrenergic blockade, ethacrynic acid or by the development of tachyphylaxis to the vasodilator effects of nitroglycerin. It has also been reported that the cyclic AMP content of vessels did not significantly increase following exposure to hyperosmotic solutions. These results suggest that vasodilation resulting from hyperosmolar solutions does not depend on beta-adrenocep- tor activation, stimulation of cyclic AMP formation, or sulfhydryl (S-H) group activation.
In the present experiments, canine cerebral arteries were examined to determine whether hyperosmolarinduced vasodilation is dependent on the alteration of extracellular and/or intracellular calcium mobilizing mechanisms. In the arteries with PGF^-induced contractions, the large contractions in response to the in- flux of extracellular calcium were markedly suppressed by the pretreatment of preparations with either mannitol or sucrose, while the small contractions caused by the release of intracellularly stored calcium were not significantly inhibited. In addition, calciuminduced contractions of K + -depolarized arteries were dose-dependently inhibited with either mannitol or sucrose, while the caffeine-induced contractions in the Ca ++ -free medium were not significantly suppressed. These results suggest that hyperosmolar solutions produce non-specific vasodilation of cerebral arteries by inhibiting influx of external calcium. It seems unlikely that hyperosmolar solutions alter cerebral artery contractions associated with intracellular calcium mobilization.
Previous studies have demonstrated that Ca + + channel blockers suppress the potassium-induced contractions of cerebral arteries more than the contractions induced by PGF^1 9 -w or serotonin. 34 However, hyperosmolar solutions inhibited the receptor operated contractions to a nearly equal, or greater extent than the contractions mediated through influx of extracellular Ca + + following the K + -induced depolarization of the cell membranes. Therefore, the mechanism for vasodilatory effect of hyperosmolar solutions seems to be somewhat different from that of so-called Ca + + channel blockers.
Cerebral blood flow increases following both intraarterial 14 and intravenous 12 -13 -" administration of mannitol. A decrease in blood viscosity has been suggested to be one of the important mechanisms for the CBF changes. 1635 It is apparent from the present results that hyperosmolar solutions possess a vasodilatory effect on the cerebral arterial smooth muscles. Therefore, it seems reasonable to assume that the direct vasodilatory effect also participates in the CBF changes following the administration of hyperosmolar solutions. However, responses of cerebral vessels to hyperosmolar solutions in vivo appear to be complicated. It has been reported that intracarotid mannitol produces dilatation of cerebral vessels, 36 while intravenous mannitol produces vasoconstriction. 16 Apparently, the mechanisms responsible for the CBF increase are different in intracarotid versus intravenous administration of mannitol. The effect seen by intracarotid injection of mannitol may be primarily caused by caliber changes of cerebral vessels due to a direct vasodilatory effect of mannitol. Thereafter, a decrease in blood viscosity 35 or an increase in PaCO 2 37 may further increase the CBF. On the other hand, it seems unlikely that the direct vasodilatory effect of mannitol plays an important role in the caliber changes of cerebral vessels following intravenous administration of mannitol. Intravenous mannitol decreases hematocrit 15 ' 35 and blood viscosity 16 ' 35 and would reduce cerebral vascular resistance.
l3 While these changes would increase CBF, an autoregulatory response would produce the constriction of cerebral vessels. Presumably, the autoregulatory response overcomes the direct vasodilatory effect of mannitol. Further studies will be necessary in order to define the mechanism for the complicated in vivo responses of cerebral vessels following the administration of hyperosmolar solutions.
In conclusion, the present results demonstrate that hyperosmolar solutions produce non-specific vasodilation of cerebral arteries in vitro. The vasodilatory effect appears to be due in part to the inhibition of the influx of external calcium. Such a vasodilatory effect probably plays an important role in the transient increase of CBF following intracarotid administration of hyperosmolar solutions.
